Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-29
2005-03-29
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S315000, C514S331000, C514S277000, C514S332000, C514S337000, C514S350000, C514S354000, C514S353000, C514S357000, C514S705000, C514S603000
Reexamination Certificate
active
06872716
ABSTRACT:
One aspect of the present invention relates to heterocyclic compounds comprising a sulfonamide moiety. A second aspect of the present invention relates to the use of the heterocyclic compounds comprising a sulfonamide moiety to treat diseases, afflictions or maladies caused at least in part by abnormal activity of one or more GPCRs or ligand-gated ion channels. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds comprising a sulfonamide moiety, and the screening of those libraries for biological activity, e.g., in animal models of psychosis.
REFERENCES:
patent: 3933829 (1976-01-01), Archibald et al.
patent: 4145427 (1979-03-01), Langbein et al.
patent: 5658908 (1997-08-01), Chang et al.
patent: 3534049 (1997-10-01), Bell
patent: 5703065 (1997-12-01), Howard, Jr.
patent: 5721255 (1998-02-01), Howard et al.
patent: 5854249 (1998-12-01), Chang et al.
patent: 5912245 (1999-06-01), Rivó et al.
patent: 5919797 (1999-07-01), Goodman et al.
patent: 5994392 (1999-11-01), Shashoua
patent: 6004982 (1999-12-01), Stupczewski et al.
patent: 6194581 (2001-02-01), Cosford et al.
patent: 6303816 (2001-10-01), Arnold et al.
patent: 6316490 (2001-11-01), Vernier et al.
patent: 20010027195 (2001-10-01), Nugiel et al.
patent: 23 47 390 (1975-04-01), None
patent: 0 481 299 (1992-04-01), None
patent: 9631478 (1996-10-01), None
patent: WO 9947515 (1999-09-01), None
patent: 0 990 653 (2000-04-01), None
patent: WO 0164633 (2001-09-01), None
patent: WO 0164634 (2001-09-01), None
Chemical abstract DN 126:7997, also cited as WO9631478 dated Oct. 1996.*
De Paulis et al, Eur. J. Med. Chem. 25/6, 507-17(1990).*
Wise et al.; “1-[3-(Diarylmino)propyl]piperidines and Related Compounds, Potential Antipsychotic Agents With Low Cataleptogenic Profiles”, J. Med. Chem. 28: 606-612 (1985).
DePaulis et al., “Potential Antipsychotic Agents”, Eur. J. Med. Chem., 25/6, 507-17 (1990); also cited as Chem. Abstrct #114:190-1991: 190.
Chemical Abstract CAPLUS DN 135:288778, also cited as U.S.P. 2001027195, dated Oct. 2001.
Chemical Abstract CAPLU DN 85:21138, also cited as U.S.P. 393829, dated Jan. 1976.
Chemical Abstract CAPLUS DN 74:3525, also cited as U.S.P. 3534049, dated Oct. 1997.
PubMed Abstract 12738054, also cited as Brain Res. Brain Res. Rev. 42/2, 123-42(2003).
PubMed Abstract 12471595, also cited as Proteins, 50/1,5-25 (2003).
International Search Report Completed on Sep. 6, 2002 and Mailed on Sep. 16, 2002.
Aquila Brian M.
Cuny Gregory D.
Hauske James R.
Radeke Heike
Shao Liming
Foley & Hoag LLP
Gordon Dana M.
Patel Sudhaker B.
Raymond Richard L.
Sepracor Inc.
LandOfFree
Antipsychotic sulfonamide-heterocycles, and methods of use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antipsychotic sulfonamide-heterocycles, and methods of use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipsychotic sulfonamide-heterocycles, and methods of use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3431335